Key facts
- The 4th AGP & DTx Summit was held in Shenzhen in May 2026.
- The summit's theme was 'Beyond Glucose'.
- Digital therapies demonstrated a 0.54% reduction in HbA1c.
- The event emphasized a shift in diabetes treatment from monitoring to intervention.
The 4th AGP & DTx Summit, themed 'Beyond Glucose,' concluded in Shenzhen in May 2026. Co-organized by SIBIONICS, the conference brought together internationally renowned experts and specialists. A key finding presented was that the application of digital therapies resulted in a 0.54% reduction in HbA1c levels. The summit underscored a broader trend in diabetes treatment, moving away from solely monitoring glucose levels towards more active intervention and therapeutic changes.